Wir sind mit live! Mehr erfahren
RMTI-Symbol

Rockwell Medical

7,43 USD
-0,55
6,89 %
Zum Börsenschluss Aktualisiert 16. Okt., 16:00 EDT
1 Tag
-6,89 %
5 Tage
-5,47 %
1 Monat
-4,74 %
3 Monate
29,67 %
6 Monate
-18,89 %
Seit Jahresbeginn
-13,9 %
1 Jahr
-37,56 %
5 Jahre
-88,04 %
10 Jahre
-98,82 %
 

Profil: Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.

Mitarbeiter: 157

Nachrichten

Positiv
Neutral
Negativ
Stimmung 3 Monate
Positiv 0 %
Neutral 77,8 %
Negativ 22,2 %
Neutral
Business Wire
vorgestern
Rockwell Medical to Release Third Quarter 2026 Results on Thursday, November 12, 2026
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the third quarter ended September 30, 2026 on Thursday, November 12, 2026.
Rockwell Medical to Release Third Quarter 2026 Results on Thursday, November 12, 2026
Neutral
Business Wire
vor 3 Tagen
Rockwell Medical to Exhibit at ASN Kidney Week 2026
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Come visit Rockwell Medical in Booth #1049 at ASN Kidney Week 2026 at the Colorado Convention Center in Denver, CO.
Rockwell Medical to Exhibit at ASN Kidney Week 2026
Neutral
Business Wire
vor 10 Tagen
Rockwell Medical Ranked No. 16 on the 2026 Fortune ‘Best Workplaces in Manufacturing & Production' List
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--This marks the 3rd consecutive year that Rockwell Medical earned this recognition—climbing the ranks from #50 (2024) and #40 (2025) to #16 (2026).
Rockwell Medical Ranked No. 16 on the 2026 Fortune ‘Best Workplaces in Manufacturing & Production' List
Neutral
Seeking Alpha
vor 2 Monaten
Rockwell Medical, Inc. (RMTI) Q2 2026 Earnings Call Transcript
Rockwell Medical, Inc. (RMTI) Q2 2026 Earnings Call Transcript
Rockwell Medical, Inc. (RMTI) Q2 2026 Earnings Call Transcript
Negativ
Zacks Investment Research
vor 2 Monaten
Rockwell Medical (RMTI) Reports Q2 Loss, Lags Revenue Estimates
Rockwell Medical (RMTI) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to a loss of $0.5 per share a year ago.
Rockwell Medical (RMTI) Reports Q2 Loss, Lags Revenue Estimates
Neutral
Business Wire
vor 2 Monaten
Rockwell Medical Announces Second Quarter 2026 Results
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical announces Q2'26 results, delivering strong year-over-year growth, expanding gross margin and generating positive operating cash flow.
Rockwell Medical Announces Second Quarter 2026 Results
Negativ
Zacks Investment Research
vor 2 Monaten
Rockwell Medical (RMTI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Rockwell Medical (RMTI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Neutral
Business Wire
vor 2 Monaten
Rockwell Medical Advances Quality and Regulatory Leadership
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Brian Cox joins Rockwell Medical as VP, Quality and Regulatory Compliance, bringing more than 20 years' healthcare experience to the Company.
Rockwell Medical Advances Quality and Regulatory Leadership
Neutral
Business Wire
vor 2 Monaten
Rockwell Medical Regains Compliance with Nasdaq Listing Requirements
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical received notice from Nasdaq that it regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2).
Rockwell Medical Regains Compliance with Nasdaq Listing Requirements
Neutral
Business Wire
vor 3 Monaten
Rockwell Medical to Release Second Quarter 2026 Results on Thursday, August 13, 2026
WIXOM, Mich.--(BUSINESS WIRE)---- $RMTI #EndStageKidneyDisease--Rockwell Medical will release its results for the second quarter ended June 30, 2026 on Thursday, August 13, 2026.
Rockwell Medical to Release Second Quarter 2026 Results on Thursday, August 13, 2026
Kursdiagramme mit Lightweight Charts™ umgesetzt